Brazil Magnetic Resonance Imaging (MRI) Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Brazil Magnetic Resonance Imaging (MRI) Market Trends and Insights

Rising Burden of Chronic Diseases

Stroke, dementia, and cancer cases are mounting as Brazil’s population ages, so serial MRI for staging, follow-up, and treatment response is routine. Neurology already accounts for one-third of Brazil Magnetic Resonance Imaging (MRI) market demand, and oncology needs are accelerating as breast and prostate protocols expand in private centers. Cardiology imaging adds incremental volume because tertiary clinics now request functional data beyond angiography. The shift from episodic care toward chronic disease management keeps repeat-scan volumes high, reinforcing closed high-field systems for lesion detection and multiparametric exams. As chronic diseases cluster in the Southeast’s dense urban areas, diagnostic chains prioritize sites near oncology and neurology reference hospitals^{[1]GE HealthCare Investor Relations, “GE HealthCare and AWS to Accelerate Imaging AI,” gehealthcare.com}.

Expanding Private Health Insurance Coverage

Roughly 25% of Brazilians hold private health plans, and those beneficiaries undergo 179 MRI exams per 1,000 covered lives each year, more than double OECD norms. Rede D'Or, Fleury, and DASA extend their branches into secondary cities to capture this demand, creating a two-tier model in which advanced modalities remain in private hands. ANS rules mandate baseline MRI reimbursement for specified indications, providing providers with predictable revenue streams, yet premium caps constrain insurers’ margins and may curb equipment replacement cycles if membership growth plateaus. Still, large chains leverage volume contracts to negotiate discounts, enabling faster payback on new 3.0 Tesla or AI-enabled units^{[2]Brazilian Ministry of Science & Technology, “Telehealth Outcomes in Primary Care: UBS+Digital,” jmir.org}.

Technological Advancements in High-Field and Helium-Free MRI

High-field (1.0–3.0 Tesla) units remain the workhorse, but Philips BlueSeal and Fujifilm ECHELON Smart eliminate liquid helium, addressing price spikes that doubled global costs between 2022 and 2024. Each conventional scanner needs roughly 2,000 liters of helium, so sealed magnets shield budgets from refill risk. AI reconstruction such as GE AIR Recon DL cuts exam times by about 36% at Rede D'Or, raising daily throughput and lowering cost per study. These gains justify premium pricing in high-volume private sites while making 3.0 Tesla platforms financially feasible even with static SUS fees. Early adopters in São Paulo and Brasília showcase the productivity case to mid-tier hospitals evaluating new purchases.

Government Investments in Public Hospital Infrastructure

A November 2025 decree earmarks R$1.7 billion (USD 340 million) for smart hospital upgrades starting 2026, aiming to add AI, 5G connectivity, and robotic surgery capacity. MRI replacements could benefit underserved North and Northeast sites if allocation favors equity, yet procurement rules and CBS/IBS tax reforms create timing risk. SUS reimbursement covers only 11-16% of actual MRI costs, so public facilities still hesitate to expand unless capital grants offset operating losses. Duty-reduction programs shorten import lead times, but tariff uncertainties complicate bids. How quickly funds translate into installed scanners will influence regional access over the next five years.

High Capital and Maintenance Costs of MRI Systems

A new 1.5 Tesla scanner costs USD 1.0–1.5 million, and 3.0 Tesla models reach USD 3.0 million. Annual service contracts consume up to 12% of the purchase price, while helium refills can add USD 40,000 per year. Import taxes can lift landed prices 30-50%, even after partial relief from the ex-tarifário regime. Private groups dilute costs across large patient volumes, but public hospitals with lower throughput find return-on-investment unattractive, reinforcing the urban-private concentration of equipment^[3].

Low Public Reimbursement Rates Under SUS

SUS fee tables reimburse only a fraction of real imaging costs, so facilities ration access and long queues persist. Judicialization compels municipalities to buy private studies at market prices, stressing budgets. Unless reimbursement aligns with operating expense, new scanners in public sites will remain scarce, widening gaps in access. CONITEC reviews new technologies cautiously, and budget limits slow protocol updates that would otherwise stimulate volume. As a result, the Brazil Magnetic Resonance Imaging (MRI) market continues to lean on private capacity for growth.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Architecture: Closed Systems Dominate, Open Platforms Gain Patient-Centric Traction

Closed units held 70.43% of 2025 revenue, underpinning the largest slice of the Brazil Magnetic Resonance Imaging (MRI) market. Image quality remains non-negotiable for neurology and oncology exams, keeping closed 1.5 Tesla and 3.0 Tesla models central to routine practice. Open designs, generally at 1.0 Tesla, expand at 7.54% annually because orthopedic, bariatric, and pediatric scans benefit from wider bores that reduce anxiety and accommodate larger body types. Diagnostic groups in São Paulo mix fleet types, pairing a 3.0 Tesla closed system with an open unit to balance throughput and comfort. Manufacturers respond by offering wide-bore hybrids such as Siemens Free.Max that merge patient access with field strength, blurring historical quality gaps.

Open units rarely match the spatial resolution of closed magnets, yet clinical protocols like musculoskeletal extremity imaging tolerate lower signal noise in exchange for positioning flexibility. Ambulatory centers exploit this trade-off to differentiate service lines while maintaining acceptable reimbursement levels. As AI accelerates reconstruction speed, the performance gulf narrows, further lifting open-system appeal for non-critical exams. Procurement choices therefore hinge on local case-mix and space constraints rather than on a simple quality hierarchy.

By Field Strength: High-Field Workhorse, Ultra-High-Field Research Frontier

High-field 1.0–3.0 Tesla equipment captured 57.43% of 2025 spending and anchors day-to-day clinical throughput, accounting for the core of the Brazil Magnetic Resonance Imaging (MRI) market size. Lower-field portable devices remain niche, serving ICU and rural outreach. Ultra-high-field scanners above 3.0 Tesla expand 7.12% each year, driven by São Paulo universities that pursue advanced neuroimaging and spectroscopy. Sealed magnets limit helium needs and make 3.0 Tesla adoption feasible even in midsize private hospitals. Hyperfine’s 0.064 Tesla Swoop targets intensive-care beds, but uptake depends on SUS reimbursement inclusion.

Academic hospitals embrace 7.0 Tesla units for research, yet budgets and infrastructure requirements cap volumes. The 1.5 Tesla band persists as the default choice for public tenders, balancing cost and coverage of approved protocols. As AI upgrades shorten scan times, 3.0 Tesla productivity rises, unlocking economic justification in centers with heavy oncology or cardiac caseloads. Equipment suppliers therefore segment offerings: workhorse 1.5 Tesla for public bids, productivity-driven 3.0 Tesla for high-volume private hubs, and 7.0 Tesla flagship systems for prestige research programs.

By Application: Neurology Leads, Oncology Accelerates

Neurology contributed 33.76% of 2025 revenue, reflecting stroke and dementia protocol growth, and anchors the largest slice of the Brazil Magnetic Resonance Imaging (MRI) market. Oncology leads growth at 7.89% through 2031 as breast, prostate, and whole-body diffusion imaging spread in private oncology networks. Cardiac MRI gains incremental ground where non-invasive viability studies replace some catheter work-ups, although training gaps slow broader uptake. Musculoskeletal and hepatobiliary imaging maintain steady but smaller contributions.

Private cancer centers deploy dedicated breast coils and, in rare cases, PET-MRI hybrids to guide biopsy and therapy monitoring. Public hospitals focus on stroke pathway mandates, sustaining neuroimaging dominance. The divergent paces leave neurology holding volume leadership but oncology adding the most incremental scanners, shaping vendor marketing and coil package bundling decisions.

By End User: Hospitals Anchor Demand, Diagnostic Centers Grow Faster

In 2025, hospitals accounted for 66.74% of expenditures, driven by their focus on emergency stroke and surgical planning services that require on-site access, thereby maintaining a dominant position in Brazil's Magnetic Resonance Imaging (MRI) market. Diagnostic imaging centers are expanding at an annual growth rate of 6.54%, supported by Rede D'Or, Fleury, and DASA's strategic penetration into secondary cities, leveraging extended operational hours and AI-driven efficiency. Ambulatory surgery centers are emerging as a niche segment by adopting open magnets for intraoperative orthopedic guidance.

High utilization of private health plans, with 179 exams per 1,000 enrollees, underpins investment strategies in diagnostic centers. However, hospitals, particularly within the SUS network, face budgetary constraints, with many scanners exceeding a decade in service. This dynamic is gradually shifting the market toward outpatient chains, which capitalize on rapid reporting capabilities and flexible scheduling, further strengthening the private sector's role in driving overall market growth.

Regulatory Landscape

MRI systems are regulated in Brazil as medical devices under ANVISA, with risk classification, labeling, and registration/notificacao regimes anchored by RDC 751/2022. For higher-risk devices (Class III/IV), market authorization requirements include compliance evidence and Good Manufacturing Practices (GMP) expectations, with ANVISA oversight extending across the product lifecycle.

Beyond product authorization, MRI site safety, quality assurance, and operational controls are governed by ANVISA Normative Instruction IN 97/2021. It sets requirements across controlled-zone practices and technical conditions such as acoustic isolation and cryogenic gas management, alongside permanent education programs for clinical staff. Conformity assessment for electro-medical equipment through INMETRO-accredited bodies adds another compliance layer that can shape supplier documentation, installation readiness, and procurement timelines for hospitals and diagnostic imaging centers.

Value Chain Analysis

Brazil's MRI value chain begins with global OEMs (GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and Fujifilm) and extends to local entities handling importation, distribution, and in-country regulatory stewardship. This includes ANVISA submissions, post-market vigilance, and field corrective actions when required. Local players also use ANVISA compliance and local assembly positioning in bids, particularly where public tenders evaluate total cost of ownership and service continuity.

Downstream, specialized logistics and site preparation feed into acceptance testing, ongoing quality control activities aligned with IN 97/2021, and long-term service contracts for uptime and coil and parts availability. Clinical operations and reporting complete the chain, with radiologist availability and workflow software (including AI reconstruction and modality connectivity) increasingly shaping value capture. Differentiation shifts from magnet hardware alone toward lifecycle services, compliance support, and throughput optimization.

Market Opportunities and Future Outlook

Compliance-driven modernization creates whitespace for turnkey MRI deployment and ongoing upkeep services. IN 97/2021 explicitly raises expectations around controlled-zone safety, acoustic isolation, and cryogenic gas handling, which supports demand for engineering design, installation qualification, periodic quality control, and structured staff training that smaller hospitals and municipal networks often outsource.

Workflow integration is another near-term opportunity. As large providers look to shorten exam times and raise asset utilization under constrained reimbursement, vendors are investing in productivity software that can be layered onto existing fleets. Philips actions in Brazil, including reinforcement of its Integrated Diagnostics approach (linking MRI with other modalities and informatics) and introducing AI-based reconstruction (SmartSpeed Precise) during JPR 2026, point to continued focus on productivity features. Helium price volatility and import dependencies also keep attention on technologies and service models that reduce helium exposure and improve parts availability, benefiting suppliers and partners with strong local support and regulatory execution.